A Mechanism of Resistance to HIV-1 Entry: Inefficient Interactions of CXCR4 with CD4 and gp120 in Macrophages  by Dimitrov, Dimiter S. et al.
l
p
t
(
n
t
o
g
e
t
i
g
h
s
t
r
a
o
e
d
t
B
E
c
U
3
Virology 259, 1–6 (1999)
Article ID viro.1999.9747, available online at http://www.idealibrary.com onRAPID COMMUNICATION
A Mechanism of Resistance to HIV-1 Entry: Inefficient Interactions
of CXCR4 with CD4 and gp120 in Macrophages
Dimiter S. Dimitrov,*,1 David Norwood,*,2 Tzanko S. Stantchev,†,2 Yanru Feng,*
Xiaodong Xiao,* and Christopher C. Broder†,1
*Laboratory of Experimental and Computational Biology, NCI-FCRDC, NIH, Frederick, Maryland 21702-1201; and †Department of Microbiology
and Immunology, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814-4799
Received March 1, 1999; returned to author for revision March 17, 1999; accepted April 5, 1999
To test the hypothesis that inefficient interactions of CXCR4 with CD4 and gp120 could affect HIV-1 entry, we incubated
macrophages, monocytes, and lymphocytes with gp120 and coimmunoprecipitated CD4 by using anti-CXCR4 antibodies. CD4
was efficiently coimmunoprecipitated in lymphocytes and monocytes but not in macrophages. Overexpression of CD4 in
macrophages resulted in detection of CD4–CXCR4 and gp120–CD4–CXCR4 complexes in parallel with the restoration of
macrophage fusion susceptibility. These results suggest a mechanism of resistance to entry of some X4 HIV-1 strains into
macrophages and a method for dissection of the initial stages of HIV entry.Key Words: HIV-1; CD4; CXCR4; coreceptors; chemokine receptors; envelope glycoprotein; membrane fusion.
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qIntroduction. It has been known for many years that T cell
ine adapted (TCLA) X4 HIV-1 strains do not infect macro-
hages as efficiently as CD41 T cells (reviewed in (1)). Al-
hough the infection could be restricted at a postentry step
2), the TCLA X4 HIV-1 envelope glycoproteins (Envs) can-
ot mediate efficient fusion of macrophages (3), suggesting
hat the entry step is also affected. Based on our previous
bservations that CXCR4 forms a complex with CD4 and
p120 from TCLA X4 HIV-1 in cell lines susceptible to HIV-1
ntry (4, 5) we hypothesized that the mechanism of resis-
ance to HIV-1 entry in macrophages could be caused by
nefficient interactions of CXCR4 with CD4 and the CD4–
p120 complex (1, 6). Here we present data supporting this
ypothesis, provide a method for dissection of the initial
tage of HIV-1 entry, and propose that inefficient interac-
ions of HIV coreceptors with CD4 and gp120 could play a
ole in the resistance to HIV entry into a variety of cells.
The views expressed in this paper are solely those of the authors,
nd they do not represent official views or opinions of the Department
f Defense or The Uniformed Services University of the Health Sci-
nces.
1 To whom correspondence and reprint requests should be ad-
ressed: Dimiter S. Dimitrov, Laboratory of Experimental and Compu-
ational Biology, DBS, NCI/FCRDC, NIH, Building 469, Room 216, P.O.
ox B, Miller Drive, Frederick, MD 21702-1201. Fax: 301-846-6189.
-mail: dimitrov@ncifcrf.gov. Christopher C. Broder, Department of Mi-
robiology and Immunology, F. Edward He´bert School of Medicine,
SUHS, 4301 Jones Bridge Road, Bethesda, MD 20814-4799. Fax:
01-295-1545. E-mail: cbroder@mxb.usuhs.mil.C2 These authors contributed equally to the research.
1Results and Discussion. We have examined the abili-
ies of prototypic TCLA X4 and R5 HIV-1 Envs (7) to
ediate cell fusion in macrophages, while modulating
he expressed levels of CD4 and/or CXCR4 or CCR5,
sing a well-characterized reporter-gene assay for HIV
nv-mediated fusion (3). Under conditions of wild-type
D4 and coreceptor levels, HeLa cells expressing the
CLA X4 Env LAV were very limited in the ability to
ediate fusion with macrophages (Table 1). However,
hey adequately supported fusion by the R5 Envs JRFL
nd ADA (Table 1) (3), although the surface concentration
f CCR5 was about the same as or lower than that of
XCR4 (Table 2). Upon high cell surface CD4 levels (on
he order of 105 molecules per cell), the LAV Env-medi-
ted fusion increased from background levels (compa-
able to those given by negative controls) to levels in the
ange of some R5 Envs (JRFL, ADA) without overex-
ressed CD4 (Table 1 and data not shown). Overexpres-
ion of CXCR4 increased fusion, although the increase
as never as high as that when CD4 was overexpressed
Table 1 and data not shown). We also found that simul-
aneous overexpression of CD4 and CXCR4 consistently
esulted in a greater than additive increase in X4 Env-
ediated fusion in macrophages. Overexpression of
CR5 or CD4 plus CCR5 also led to significant increase
n R5 Env-mediated fusion. These data indicate that ef-
icient fusion mediated by LAV Env results only through
he elevation of receptor levels, supposedly when ade-
uate complex formation can occur between CXCR4,
D4, and gp120.
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2 RAPID COMMUNICATIONTo test the hypothesis that the mechanism of resis-
ance to Env-mediated membrane fusion of macro-
hages could be caused by inefficient interactions be-
ween CXCR4, CD4, and gp120, CXCR4-expressing
onocytes, lymphocytes, and macrophages were incu-
ated with HIV-1 gp120 (IIIB/BH8) and CD4 was coim-
unoprecipitated by using anti-CXCR4 monoclonal anti-
odies (mAbs) (Fig. 1). CD4 was efficiently coimmuno-
recipitated in monocytes and lymphocytes but not in
acrophages (Fig. 1), while CD4 coimmunoprecipitated
ith anti-CCR5 antibodies can be readily detected under
imilar conditions even in the absence of gp120 (Fig. 1)
5). Upon high CD4 expression, which allows for mem-
rane fusion of the macrophages with LAV Env, we were
ble to coimmunoprecipitate the CD4–CXCR4 complex
Fig. 2). The amount of CD4–CXCR4 complex detected
as enhanced upon the inclusion of soluble gp120, as
reviously observed for coimmunoprecipitates from cell
ines (4, 5). In fact, the level of CD4–CXCR4 or gp120–
D4–CXCR4 complexes increased, as did the cell fusion,
pon overexpression of both CD4 and CXCR4 (with or
ithout gp120, Fig. 2, lanes 5 and 6, respectively). Similar
esults were obtained for macrophages from several
ifferent donors (data not shown). These findings provide
biochemical correlate to the notion that the resistance
T
HIV-1 Env-Mediated Fusion Measured by
Env/Rec No target cells WR CD4
No Env 0.3 6 0.1 0.4 6 0.2 0.3 6 0.4
LAV 0.4 6 0 1.0 6 0.4 6 6 1
JRFL 0.2 6 0 14 6 3 69 6 18
ADA 0.2 6 0 22 6 4 91 6 7
Note. Macrophages were infected with vaccinia viruses encoding C
CBYF1 (encoding CXCR4), vvCCR5-1107 (encoding CCR5)) or with com
ncubated overnight (12 h) at 31°C. Effector (HeLa) cells were infected
nd reporter virus vCB21R–LacZ encoding the Escherichia coli LacZ g
atio of 1:1 (total number of cells equaling 2 3 105 in 96-well plate for
colorimetric assay of b-galactosidase activity in detergent cell lysat
nfected HeLa cells were measured; the numbers are the mean and s
umber of fusion events.
TABLE 2
Flow Cytometry Analysis of Macrophages Stained with Anti-CXCR4
mAbs and the Anti-CCR5 mAb m182
Abs
CXCR4
(4G10)
CXCR4
(12G5)
CCR5
(m182)
CD4
(OKT4)
E molecules 12,000 18,000 12,000 5000
Note. The numbers represent the number of PE molecules bound to
he macrophage surface where the background is subtracted and are
pproximately equal to the number of receptor molecules at the mac-gophage surface.o TCLA X4 HIV-1 entry in macrophages is due to the
nability of these cells to efficiently form complexes be-
ween CD4, CXCR4, and gp120 and provide direct evi-
ence of a correlation among the cell surface concen-
rations of CD4–CXCR4 complexes, gp120–CD4–CXCR4
omplexes, and Env-mediated membrane fusion.
These results are important not only because they
uggest a likely and possibly universal mechanism ex-
laining a number of observations that expression of
D4 and HIV coreceptors is not sufficient for HIV entry
nto certain cells, particularly macrophages, but also
ecause they directly demonstrate a correlation between
he ability of an X4 HIV-1 Env to mediate membrane
usion and the formation of the gp120–CD4–CXCR4 com-
lex as an initial stage of HIV-1 entry. Such a mechanism
as been proposed by several investigators (4, 8–11) but
ad not been formally experimentally demonstrated.
hile this paper was under review, another independent
tudy suggested that CD4–CXCR4 association is critical
or X4 Env-mediated fusion in macrophages and the
educed activities of X4 isolate Env interaction were due
o poor complex formation with a high molecular weight
pecies of CXCR4 (12). However, our report differs in
everal significant respects. One critical distinction is
hat we cannot detect CD4–CXCR4 complexes in either
onocytes or macrophages without the addition of Env,
nd when added we immunoprecipitate gp120–CD4–
XCR4 complexes only from monocytes and lympho-
ytes, but not from macrophages. In addition, we also
orrelate the restoration of fusion to the appearance of
p120–CD4–CXCR4 trimolecular complex formation, and
e demonstrate the penultimate enhancement of X4
nv-mediated fusion in macrophages through the simul-
aneous overexpression of both CD4 and CXCR4.
Interestingly, it appears that the formation of the CD4–
XCR4 complex is enhanced by the constitutive associ-
tion between CD4 and CXCR4 even in the absence of
inia Virus-Based Cell–Cell Fusion Assay
XCR4 CCR5 CD4 1 CXCR4 CD4 1 CCR5
.4 6 0 0.7 6 0.4 0.2 6 0 0.1 6 0.1
.9 6 0.7 0.8 6 0.3 40 6 10 9 6 3
6 5 27 6 11 100 6 2 230 6 80
6 2 56 6 12 92 6 35 176 6 41
CR4, or CCR5 (control wild-type vaccinia (WR), vCB3 (encoding CD4),
ns of two viruses and with vTF7-3 (encoding T7 RNA polymerase) and
ccinia viruses encoding an X4 HIV-1 Env (LAV) or R5 Env (JRFL, ADA)
ked to the T7 promoter. The two populations of cells were mixed at a
duplicate). Fusion was allowed to proceed for 2 h and quantitated by
Env indicates infection with only vCB21R–LacZ; no target cells, only
deviation of the optical density readings and are proportional to theABLE 1
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3RAPID COMMUNICATIONhough the association of CXCR4 with CD4 is much
eaker than the CCR5–CD4 interaction (5), the CD4–
XCR4 complex still can serve as a nucleus for the
ubsequent formation of multimeric HIV Env–CD4–
XCR4 complexes leading to formation of fusion pores
nd fusion. This is supported by our finding that the
umber of CD4–CXCR4 complexes correlates with both
he number of gp120–CD4–CXCR4 complexes and the
xtent of fusion. Our results are in agreement with the
ork of Kabat and co-workers (13), where R5 primary
solates were shown to have a CD4 and CCR5 interde-
endent relationship for fusion and entry, and it was
roposed that CD4 and CCR5 might directly interact.
egarding primary macrophages where CCR5 is in ex-
ess of CD4 we also note that the elevation of CD4 and
ot CCR5 had the greater effect in fusion enhancement.
urther, it was earlier concluded that some primary pa-
ient-derived X4 isolates would bind weakly to CD4 and
referentially infect cells that coexpress CXCR4 and
arge amounts of CD4 (14). Our results with macro-
hages support this notion as well and suggest that the
ariable results of X4 isolate infection or fusion in human
acrophages, whether they be primary or lab-adapted
trains, is the result of a particular isolate’s ability to
rchestrate an adequate number of Env–CD4–CXCR4
omplexes, perhaps mediated through a mechanism of
ifferential affinities for the two receptor proteins.
What causes the inefficient interaction of macrophage
XCR4 with CD4 and the CD4–gp120 complex is pres-
ntly unclear. Previously, we speculated on the possibil-
ty that the interaction of CD4 with CCR5 is stronger than
hat with CXCR4, leading to larger numbers of CD4–
CR5 complexes than CD4–CXCR4 complexes and that
his may be a significant factor in the observed differen-
ial susceptibility of cells, including macrophages, to
ntry of X4 and R5 HIV isolates, especially at low levels
f CD4 (1, 6, 15). However, we recently demonstrated that
or some U937 cell clones (minus clones), which resist
IV-1 entry and behave similarly to macrophages but do
ot express CCR5 (16), CXCR4 also does not efficiently
FIG. 1. Coimmoprecipitation of CD4 induced by gp120 in monocytes,
ymphocytes, and macrophages. Lanes 1–3 represent CD4 Western
lots of immunoprecipitates (by the anti-CXCR4 mAb 4G10) from mono-
ytes, lymphocytes, and macrophages, respectively, incubated with 10
g/ml gp120. Lane 4 represents a CD4 Western blot of macrophagefysates immunoprecipitated by the anti-CCR5 mAb 5C7.nteract with CD4 and the CD4–gp120 complex (Xiao et
l., submitted for publication). Further, we have demon-
trated a constitutive association of CD4 and CCR5 in a
ariety of cells even in the absence of HIV gp120 (5, 37).
he fact that the anti-CXCR4 mAb 12G5 has been dem-
nstrated to differentially inhibit HIV-1 infection in both a
ell type and virus strain dependent manner (17) has
uggested another possibility—that the CXCR4 mole-
ule itself is somehow posttranslationally differentially
rocessed in macrophages, resulting in its being differ-
ntially utilized by various HIV-1 isolates (18). A modified
XCR4 protein may have a weaker affinity or ability to
ssociate with CD4 in macrophages or be utilized only
y certain primary X4 or R5X4 HIV-1 isolates possessing
nvs capable of circumventing this restriction, perhaps
hrough a different binding interaction. Such a possibility
s supported by our recent observation that CXCR4
–linked glycosylation has a profound influence on
XCR4 coreceptor activity (Chabot et al., unpublished
ata). Indeed, it has been proposed that a different mo-
ecular weight species is evident in macrophages which
annot form complexes with CD4 (12). However, we
ound that for both macrophages (data not shown) and
937 minus cells (37) CXCR4 is not detectable by West-
rn blotting using an anti-CXCR4 mAb or several rabbit
olyclonal serums, all of which otherwise are very effi-
ient in detecting CXCR4 in T lymphocytes or recombi-
ant expressed CXCR4. Thus, at this time we cannot
onfirm the presence of a high molecular weight form of
XCR4 in macrophages and attribute this discrepancy to
ifferent reagents and/or assay sensitivities.
These data not only detail a mechanism of macro-
hage resistance to infection by HIV-1 but also suggest
possibility for a general mechanism of resistance to
IV-1 entry into a variety of cells. We have also not
verlooked a potential implication of these results re-
arding HIV vaccine development. That is, our findings
emonstrate a correctable, measurable biochemical and
FIG. 2. Immunoprecipitation of CD4–CXCR4 and gp120–CD4–CXCR4
omplexes. Lane 1, macrophages infected with wild-type vaccinia virus
ithout gp120; lane 2, as in lane 1 but with gp120; lane 3, overexpres-
ion of CD4 by vaccinia without gp120; lane 4, as in lane 3 but with
p120; lane 5, simultaneous infection with vaccinia viruses encoding
he genes for CD4 and CXCR4 without gp120; lane 6, as in lane 5 but
ith gp120; and lane 7, 1 ng of sCD4 (1010 molecules) as a quantitative
arker.unctional defect in the ability of a TCLA X4 isolate Env
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4 RAPID COMMUNICATIONlycoprotein to associate with receptors and induce fu-
ion of primary macrophages, and this suggests that
uch Envs are indeed structurally and functionally dis-
inct from primary isolate X4 or R5X4 Envs, which further
uestions their utility as an appropriate molecule in the
evelopment of HIV vaccines. Thus, understanding the
etails of the gp120–CD4–coreceptor interaction is of
articular significance for defining further, or to perhaps
nhance the presentation of, the conserved and only
ransiently exposed epitopes or neoepitopes that may be
mportant for eliciting broadly effective anti-HIV Env-
ased humoral response (19, 20).
It has been recently demonstrated that some primary
4 HIV-1 strains are able to enter macrophages (21, 22,
2a) and that an X4 HIV strain can cause a rapid decline
f CD4 cells in individuals who are homozygous for the
2-bp deletion in the gene coding for CCR5 (23). How-
ver, it is well established that TCLA X4 HIV-1 strain Envs
annot mediate fusion or fusion is inefficient with pri-
ary human macrophages (3). Further, it has been ob-
erved that a significant proportion of primary X4 HIV-1
solates cannot enter macrophages (R. Collman, per-
onal communication). In addition, the methods of mac-
ophage differentiation (usage of GM-CSF or LPS) influ-
nce CD4 and coreceptor expression (24–27), and hence
ay differentially affect the entry efficiency of both X4
nd R5 viruses in in vitro assays. Finally, although there
re single reports of infected homozygous defective
CR5 patients, it is well established that R5 strains are
nvolved in over 90% of HIV transmissions, while X4
trains appear relatively late in the course of infection
28) (reviewed in (29)).
In conclusion, the results presented here suggest that
nefficient formation of CD4–CXCR4 and gp120–CD4–
XC4 complexes does play an important role for the
echanism of cell resistance to HIV-1 Env-mediated
usion and may have important implications for the
echanism of macrophage resistance to entry of X4
IV-1 strains in vivo.
Materials and Methods. Cells, vaccinia viruses, gp120,
CD4, and antibodies. Human monocytes and lympho-
ytes were obtained from peripheral blood. Monocyte-
erived macrophages were prepared by countercurrent
entrifugation elutriation of PBMCs and differentiation as
reviously described (30). The vaccinia viruses used to
verexpress CD4 (vCB3) and CXCR4 (vCBYF1) were pre-
iously described, respectively, in (31, 32). The vaccinia
irus for CCR5 (vvCCR5-1107) was developed by using
he CCR5 cDNA from pCDNA3 (provided by M. Parmen-
ier) which was subcloned into the SmaI site of pMC1107
33) by BamHI–XbaI restriction and blunt-end cloning into
he SmaI site. The vaccinia viruses expressing different
IV-1 Envs were previously described (3). The HIV Env
p120 was produced by co-infection of BS-C-1 cells
ATCC CCL26) with vaccinia virus recombinant vPE6 via
he hybrid vaccinia virus–T7 system (34) with a multiplic- Dty of infection (m.o.i.) of 10 PFU/cell under serum-free
edia (OPTI-MEM, Life Technologies, Gaithersburg, MD)
onditions and purified from the culture supernatants
0 h postinfection by affinity chromatography using lentil
ectin–Sepharose (Amersham Pharmacia Biotech, Pisca-
away, NJ) as previously described (35). Soluble CD4
sCD4) and the anti-CD4 polyclonal antibody T4-4 were
btained through the AIDS Research and Reference Re-
gent Program from R. Sweet (SmithKline and Beechman
harmaceuticals). The anti-CD4 mAb OKT4 was pur-
hased from Ortho Diagnostic. The anti-CCR5 mAb m182
as purchased from R&D Systems (Minneapolis, MN).
he anti-CXCR4 mAb 12G5 was a kind gift from J. Hoxie
University of Pennsylvania, Philadelphia, PA). The anti-
XCR4 mAb 4G10 was raised against a peptide from the
XCR4 N-terminus.
Immunoprecipitation. Cells (typically 5–10 3 106 per
ample) were washed once with phosphate-buffered sa-
ine (PBS) and then resuspended in PBS at a final density
f 107/ml. Immunoprecipitating antibodies at the required
oncentration, typically 1.5–3 mg/ml, were added to the
ell suspension and incubated with gentle mixing for 1 h
t 37°C. Cells were then pelleted by centrifugation and
esuspended in lysis buffer (1% Brij97, 5 mM iodoacet-
mide (added immediately before use), 150 mM NaCl, 20
M Tris (pH 8.2), 20 mM EDTA, and protease inhibitors)
t 4°C for 1 h with gentle mixing. The nuclei were
elleted by centrifugation at 14,000 rpm for 25 min in a
efrigerated Eppendorf centrifuge. Protein G–Sepharose
eads (Sigma, St. Louis, MO) prewashed with PBS were
dded to the samples and incubated at 4°C for 14 h. The
eads were then washed four times with 1 ml of ice cold
ysis buffer. Samples were then eluted by adding 43
ample buffer for SDS–PAGE gels and boiled for 5 min or
eft overnight at 37°C. They were run on a 10% SDS–
AGE gel and were electrophoretically transferred to
itrocellulose membranes. The membranes were
locked with 20 mM Tris–HCI (pH 7.6) buffer containing
40 mM NaCl, 0.1% Tween 20, and 5% nonfat powdered
ilk. These membranes were incubated with the respec-
ive antibodies, then washed, incubated with horseradish
eroxidase (HRP)-conjugated secondary antibodies, and
eveloped by using the supersignal chemiluminescent
ubstrate from Pierce (Rockford, Il).
Flow Cytometry. Cells (typically 0.5 mln) were incu-
ated for 1 h on ice with the antibodies (10 mg/ml), then
he cells were washed and incubated for another hour on
ce with rabbit IgG (10 mg/ml) (Sigma, St. Louis, MO), and
hen washed and incubated for 1 h with an anti-mouse
hycoerythrin-conjugated polyclonal antibody (Sigma).
he cells were washed and fixed with paraformaldehyde
n ice for 10 min. The flow cytometry measurements
ere performed with FACSaliber (Becton–Dickinson, San
ose, CA). Calibrating beads with a known number of
hycoerythrin molecules were purchased (Becton–
ickinson) and used for calibration of the signal intensity.
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5RAPID COMMUNICATIONhe number of receptor molecules was approximately
stimated from the known signal intensity by using the
quation describing the intensity of the calibrating
eads, assuming that each antibody molecule is conju-
ated on average with two phycoerythrin molecules and
inds to two receptor molecules.
Cell Fusion Assay. The cell–cell fusion assay was
reviously described (36). The extent of fusion was quan-
itated colorimetrically.
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